SICLOPPS cyclic peptide libraries in drug discovery.

A. Tavassoli

DOI: https://doi.org/10.1016/j.cbpa.2017.02.016

IF: 8.972

2017-06-01

Current Opinion in Chemical Biology

Abstract:

What problem does this paper attempt to address?

Next Generation SICLOPPS Screening for the Identification of Inhibitors of the HIF-1α/HIF-1β Protein-Protein Interaction

Alexander McDermott,Leonie M Windeln,Jacob S D Valentine,Leonardo Baldassarre,Andrew D Foster,Ali Tavassoli

DOI: https://doi.org/10.1021/acschembio.4c00494

2024-10-18

Abstract:Split-intein circular ligation of proteins and peptides (SICLOPPS) is a method for generating intracellular libraries of cyclic peptides that has yielded several first-in-class inhibitors. Here, we detail a revised high-content, high-throughput SICLOPPS screening protocol that utilizes next-generation sequencing, biopanning, and computational tools to identify hits against a given protein-protein interaction. We used this platform for the identification of inhibitors of the HIF-1α/HIF-1β protein-protein interaction. The revised platform resulted in a significantly higher positive hit rate than that previously reported for SICLOPPS screens, and the identified cyclic peptides were more active in vitro and in cells than our previously reported inhibitors. The platform detailed here may be used for the identification of inhibitors of a wide range of other targets.
Methods for generating and screening libraries of genetically encoded cyclic peptides in drug discovery

Catrin Sohrabi,Andrew Foster,Ali Tavassoli

DOI: https://doi.org/10.1038/s41570-019-0159-2

IF: 34.5695

2020-01-17

Nature Reviews Chemistry

Abstract:Drug discovery has traditionally focused on using libraries of small molecules to identify therapeutic drugs, but new modalities, especially libraries of genetically encoded cyclic peptides, are increasingly used for this purpose. Several technologies now exist for the production of libraries of cyclic peptides, including phage display, mRNA display and split-intein circular ligation of peptides and proteins. These different approaches are each compatible with particular methods of screening libraries, such as functional or affinity-based screening, and screening in vitro or in cells. These techniques allow the rapid preparation of libraries of hundreds of millions of molecules without the need for chemical synthesis, and have therefore lowered the entry barrier to generating and screening for inhibitors of a given target. This ease of use combined with the inherent advantages of the cyclic-peptide scaffold has yielded inhibitors of targets that have proved difficult to drug with small molecules. Multiple reports demonstrate that cyclic peptides act as privileged scaffolds in drug discovery, particularly against 'undruggable' targets such as protein–protein interactions. Although substantial challenges remain in the clinical translation of hits from screens of cyclic-peptide libraries, progress continues to be made in this area, with an increasing number of cyclic peptides entering clinical trials. Here, we detail the various platforms for producing and screening libraries of genetically encoded cyclic peptides and discuss and evaluate the advantages and disadvantages of each approach when deployed for drug discovery.

chemistry, multidisciplinary
A Tag‐Free Platform for Synthesis and Screening of Cyclic Peptide Libraries

Angele Bruce,Victor Adebomi,Patrick Czabala,Jonathan Palmer,Gaurav Bhardwaj,Monika Raj,William M. McFadden,Zachary C. Lorson,Ryan. L. Slack,S. G. Sarafianos

DOI: https://doi.org/10.1002/anie.202320045

2024-03-28

Angewandte Chemie International Edition

Abstract:In the realm of high-throughput screening (HTS), macrocyclic peptide libraries traditionally necessitate decoding tags, essential for both library synthesis and identifying hit peptide sequences post-screening. Our innovation introduces a tag-free technology platform for synthesizing cyclic peptide libraries in solution and facilitates screening against biological targets to identify peptide binders through unconventional intramolecular CyClick and DeClick Chemistries (CCDC) discovered within our research. This combination allows for the synthesis of diverse cyclic peptide libraries, the incorporation of various amino acids, and facile linearization and decoding of cyclic peptide binder sequences. Our sensitivity-enhancing derivatization method, utilized in tandem with nano LC-MS/MS, enables the sequencing of peptides even at exceedingly low picomolar concentrations. Employing our technology platform, we've successfully unearthed novel cyclic peptide binders against a monoclonal antibody and the first cyclic peptide binder of HIV CAPSID protein responsible for viral infections as validated by microscale thermalshift assays (TSA), biolayer Interferometry (BLI) and functional assays.

chemistry, multidisciplinary
Design of cyclic peptides as novel inhibitors of ICOS/ICOSL interaction

Somaya A. Abdel-Rahman,Brianda L Santini,Laura Calvo-Barreiro,Martin Zacharias,Moustafa Gabr

DOI: https://doi.org/10.1016/j.bmcl.2024.129599

IF: 2.94

2024-01-07

Bioorganic & Medicinal Chemistry Letters

Abstract:Compared to small molecules and antibodies, cyclic peptides exhibit unique biochemical and therapeutic attributes in the realm of pharmaceutical applications. The interaction between the inducible costimulator (ICOS) and its ligand (ICOSL) plays a key role in T -cell differentiation and activation. ICOS/ICOSL inhibition results in a reduction in the promotion of immunosuppressive regulatory T cells (Tregs) in both hematologic malignancies and solid tumors. Herein, we implement the computational cPEPmatch approach to design the first examples of cyclic peptides that inhibit ICOS/ICOSL interaction. The top cyclic peptide from our approach possessed an IC 50 value of 1.87 ± 0.15 μM as an ICOS/ICOSL inhibitor and exhibited excellent in vitro pharmacokinetic properties as a drug candidate. Our work will lay the groundwork for future endeavors in cancer drug discovery, with the goal of developing cyclic peptides that target the ICOS/ICOSL interaction.

chemistry, medicinal, organic
Imbuing peptide libraries with drug-likeness

Sunit Pal,Peter 't Hart

DOI: https://doi.org/10.1038/s41589-023-01524-x

IF: 14.8

2024-01-20

Nature Chemical Biology

Abstract:The rules for designing cyclic peptides with drug-like properties are unclear. Two studies now show how cyclic peptide libraries can be created to optimize properties such as cell permeability before screening for binding activity. The approach has led to a macrocyclic peptide inhibitor for KRAS that has reached clinical trials.

biochemistry & molecular biology
Tetrazine cyclized peptides for one-bead-one-compound library: Synthesis and sequencing

Samir Das,Arundhati Nag

DOI: https://doi.org/10.1016/bs.mie.2024.04.015

2024-04-27

Methods in Enzymology

Abstract:While most FDA-approved peptide drugs are cyclic, robust cyclization chemistry of peptides and the deconvolution of the cyclic peptide sequences using tandem mass spectrometry render cyclic peptide drug discovery difficult. In this chapter, the protocol for the successful synthesis of tetrazine-linked cyclic peptide library in solid phase, which shows both robust cyclization and easy sequence deconvolution, is described. The protocol for the linearization and cleavage of cyclic peptides from the solid phase by simple UV light irradiation, followed by accurate sequencing using tandem mass spectrometry, is described. We describe the troubleshooting for this dithiol bis-arylation reaction and for the successful cleavage of the aryl cyclic peptide into linear form. This method for efficient solid-phase macrocyclization can be used for the rapid production of loop-based peptides and screening for inhibition of protein–protein interactions, by using the covalent inverse electron-demand Diels Alder reaction to supplement the non-covalent interaction between a protein and its peptide binder, isolating highly selective peptides in the process.

biochemistry & molecular biology,biochemical research methods
A novel cyclic peptide library immobilized on gel‐type beads focusing on rapid construction and characterization for comprehensive drug discovery

Toru Sasaki,Takeshi Kasama,Kiyoshi Nokihara

DOI: https://doi.org/10.1111/cbdd.14331

2023-09-02

Abstract:The paper describes a concept for discovering novel medicinal targets or binding modes as well as lead compounds by the one‐peptide‐on‐one‐bead technology. The building blocks used for cyclic peptides were selected based on the previous development of peptidic drugs. The common structure of the libraries allows a rapid construction and characterization of a single bead. Medium sized molecules such as peptides and macrocycles have recently drawn much attention as potent sources of medicinal lead compounds, whereas the possibility of obtaining a practical drug from them remains limited. The present paper describes a concept of discovering novel medicinal targets or binding modes as well as lead compounds by the one‐peptide‐on‐one‐bead (OPOB) technology for comprehensive screening. The difficulty and problems in conventional drug discovery methods that generally deal with one predetermined target are considered. The building blocks used for the present libraries were selected based on previous results in development of peptidic drugs. Each constituent has the common structure of cyclic form prepared by disulfide of cysteinyl residues or thioether linkages, additionally a methionine residue was inserted for the site‐specific rapid cleavage by cyanogen bromide to liberate the immobilized peptides allowing reliable characterization by MALDI‐TOF‐MS/MS without LC‐purification. Thus, a high throughput construction method for cyclic peptide libraries as well as characterization of single bead are proposed for drug discovery.

biochemistry & molecular biology,chemistry, medicinal
Screening macrocyclic peptide libraries by yeast display allows control of selection process and affinity ranking

Sara Linciano,Ylenia Mazzocato,Zhanna Romanyuk,Filippo Vascon,Lluc Farrera Soler,Edward Will,Yuyu Xing,Shiyu Chen,Yoichi Kumada,Marta Simeoni,Alessandro Scarso,Laura Cendron,Christian Heinis,Alessandro Angelini

DOI: https://doi.org/10.1101/2024.08.24.609237

2024-08-25

Abstract:Macrocyclic peptides provide an attractive modality for drug development due to their ability to bind challenging targes, their small size, and amenability to powerful evolution techniques such as phage or mRNA display. While these technologies proved capable of generating and screening extremely large libraries and yielded ligands to already many targets, they often do not identify the best binders within a library due to the difficulty of monitoring performance and controlling selection pressure. Furthermore, only a small number of enriched ligands can typically be characterised due to the need of chemical peptide synthesis and purification prior to characterisation. In this work, we address these limitations by developing a yeast display-based strategy for the generation, screening and characterisation of structurally highly diverse disulfide-cyclised peptides. Analysis and sorting by quantitative flow cytometry enabled monitoring the performance of millions of individual macrocyclic peptides during the screening process and allowed us identifying macrocyclic peptide ligands with affinities in the low micromolar to high picomolar range against five highly diverse protein targets. X-ray analysis of a selected ligand in complex with its target revealed optimal shape complementarity, large interaction surface, constrained peptide backbones and multiple inter- and intra-molecular interactions, rationalising the high affinity and exquisite selectivity. The novel technology described here offers a facile, quantitative and cost-effective alternative to rapidly and efficiently generate and characterise fully genetically encoded macrocycle peptide ligands with sufficiently good binding properties to even therapeutically relevant targets.

Biochemistry
Large Libraries of Structurally Diverse Macrocycles Suitable for Membrane Permeation

Alexander L Nielsen,Zsolt Bognar,Ganesh K Mothukuri,Anne Zarda,Mischa Schuttel,Manuel L Merz,Xinjian Ji,Edward Will,Monica Chinellato,Christian R.O Bartling,Kristian Stromgaard,Laura Cendron,Alessandro Angelini,Christian Heinis

DOI: https://doi.org/10.1002/anie.202400350

2024-04-13

Angewandte Chemie International Edition

Abstract:Macrocycles offer an attractive format for drug development due to their good binding properties and potential to cross cell membranes. To efficiently identify macrocyclic ligands for new targets, methods for the synthesis and screening of large combinatorial libraries of small cyclic peptides were developed, many of them using thiol groups for efficient peptide macrocyclization. However, a weakness of these libraries is that invariant thiol-containing building blocks such as cysteine are used, resulting in a region that does not contribute to library diversity but increases molecule size. Herein, we synthesized a series of structurally diverse thiol-containing elements and used them for the combinatorial synthesis of a 2,688-member library of small, structurally diverse peptidic macrocycles with unprecedented skeletal complexity. We then used this library to discover potent thrombin and plasma kallikrein inhibitors, some also demonstrating favorable membrane permeability. X-ray structure analysis of macrocycle-target complexes showed that the size and shape of the newly developed thiol elements are key for binding. The strategy and library format presented in this work significantly enhance structural diversity by allowing combinatorial modifications to a previously invariant region of peptide macrocycles, which may be broadly applied in the development of membrane permeable therapeutics.

chemistry, multidisciplinary
Linearizable Macrocyclic Peptide Libraries for Affinity Selection-Mass Spectrometry

Bradley L. Pentelute,Michael A. Lee,Joseph S. Brown,Charlotte E. Farquhar,Andrei Loas

DOI: https://doi.org/10.26434/chemrxiv-2024-vpstm

2024-02-05

Abstract:Macrocyclic peptides are attractive for therapeutic development but have been limited in their application to combinatorial library selection from synthetic libraries. Here, we establish a synthetic approach based on split-pool chemistry to produce 100-million membered macrocyclic libraries containing natural and non-natural amino acids. Near-quantitative intramolecular disulfide formation is facilitated by rapid (<10 minute) oxidation by iodine to prepare macrocyclic synthetic libraries in solution. Treatment with dithiothreitol post-affinity selection enables near-quantitative reduction of the library members, rendering the linear analogs amenable to standard tandem mass spectrometry sequencing. We demonstrate the utility of these libraries to discover novel macrocyclic binders to cadherin-2 and the anti-hemagglutinin antibody clone 12ca5. The lead cadherin-binding peptide (CBP) is endowed with nanomolar binding affinity measured by biolayer interferometry (BLI, apparent dissociation constant KD = 53 nM). Structure-activity relationship (SAR) studies including alanine and D-amino acid scans reveal the amino acids responsible for driving affinity (hot-spots) and the positions tolerating mutagenesis (cold-spots). Informed by SAR data, two new macrocyclic libraries are designed to derivatize these positions with a variety of abiotic amino acids based on the hot- and cold-spots. Following affinity selection and experimental validation by BLI, 10 high-affinity ligands out of 10 discovered were identified from the library that derivatized the CBP cold-spots, while zero of the two peptide ligands discovered from the hot-spot library were high-affinity binders. Of these noncanonical CBPs (NCBP), NCBP-4 demonstrates improved affinity to cadherin-2 (KD = 29 nM). Overall, we expect that this work will pioneer the use of large-scale macrocyclic libraries to further catalyze therapeutic peptide discovery and development.

Chemistry
The coming of age of cyclic peptide drugs: an update on discovery technologies

Sophia You,Glen McIntyre,Toby Passioura

DOI: https://doi.org/10.1080/17460441.2024.2367024

2024-06-15

Expert Opinion on Drug Discovery

Abstract:Introduction Cyclic peptides are an established class of pharmaceuticals, with the ability to bind to a broader range of protein targets than traditional small molecules while also being capable of oral availability and cell penetration. Historically, cyclic peptide drugs have been discovered almost exclusively through natural product mining approaches; however, the last two decades have seen the development of display screening approaches capable of rapidly identifying de novo (i.e. not natural product derived) cyclic peptide ligands to targets of interest.

pharmacology & pharmacy
CyclicPepedia: a knowledge base of natural and synthetic cyclic peptides

Lei Liu,Liu Yang,Suqi Cao,Zhigang Gao,Bin Yang,Guoqing Zhang,Ruixin Zhu,Dingfeng Wu

DOI: https://doi.org/10.1093/bib/bbae190

IF: 9.5

2024-03-27

Briefings in Bioinformatics

Abstract:Abstract Cyclic peptides offer a range of notable advantages, including potent antibacterial properties, high binding affinity and specificity to target molecules, and minimal toxicity, making them highly promising candidates for drug development. However, a comprehensive database that consolidates both synthetically derived and naturally occurring cyclic peptides is conspicuously absent. To address this void, we introduce CyclicPepedia (https://www.biosino.org/iMAC/cyclicpepedia/), a pioneering database that encompasses 8744 known cyclic peptides. This repository, structured as a composite knowledge network, offers a wealth of information encompassing various aspects of cyclic peptides, such as cyclic peptides’ sources, categorizations, structural characteristics, pharmacokinetic profiles, physicochemical properties, patented drug applications, and a collection of crucial publications. Supported by a user-friendly knowledge retrieval system and calculation tools specifically designed for cyclic peptides, CyclicPepedia will be able to facilitate advancements in cyclic peptide drug development.

biochemical research methods,mathematical & computational biology
Selection of Nucleotide-Encoded Mass Libraries of Macrocyclic Peptides for Inaccessible Drug Targets

Kilian Colas,Daniel Bindl,Hiroaki Suga

DOI: https://doi.org/10.1021/acs.chemrev.4c00422

IF: 62.1

2024-10-27

Chemical Reviews

Abstract:Technological advances and breakthrough developments in the pharmaceutical field are knocking at the door of the "undruggable" fortress with increasing insistence. Notably, the 21st century has seen the emergence of macrocyclic compounds, among which cyclic peptides are of particular interest. This new class of potential drug candidates occupies the vast chemical space between classic small-molecule drugs and larger protein-based therapeutics, such as antibodies. As research advances toward...

chemistry, multidisciplinary
Cyclotides, a Novel Ultrastable Polypeptide Scaffold for Drug Discovery

Andrew Gould,Yanbin Ji,Teshome L Aboye,Julio A Camarero,Teshome L. Aboye,Julio A. Camarero

DOI: https://doi.org/10.2174/138161211798999438

IF: 3.31

2011-12-01

Current Pharmaceutical Design

Abstract:Cyclotides are a unique and growing family of backbone cyclized peptides that also contain a cystine knot motif built from six conserved cysteine residues. This unique circular backbone topology and knotted arrangement of three disulfide bonds makes them exceptionally stable to thermal, chemical, and enzymatic degradation compared to other peptides of similar size. Aside from the conserved residues forming the cystine knot, cyclotides have been shown to have high variability in their sequences. Consisting of over 160 known members, cyclotides have many biological activities, ranging from anti-HIV, antimicrobial, hemolytic, and uterotonic capabilities; additionally, some cyclotides have been shown to have cell penetrating properties. Originally discovered and isolated from plants, cyclotides can also be produced synthetically and recombinantly. The high sequence variability, stability, and cell penetrating properties of cyclotides make them potential scaffolds to be used to graft known active peptides or engineer peptide-based drug design. The present review reports recent findings in the biological diversity and therapeutic potential of natural and engineered cyclotides.

pharmacology & pharmacy
Cyclic, Cell-Penetrating Peptides Tailor-Made for the Creation of Peptide Libraries with Intrinsic Cell Permeability

Nicolas A. Abrigo,Kara Dods,Koushambi Mitra,Kaylee Newcomb,Anthony Le,Matthew Hartman

DOI: https://doi.org/10.26434/chemrxiv.12445226.v1

2020-06-12

Abstract:The discovery of high-affinity peptides to many intracellular targets has become feasible through the development of diverse macrocyclic peptide libraries. But lack of cell permeability is a key feature hampering the use of these peptides as therapeutics. Here, we develop a set of small, cyclic peptide carriers that efficiently carry cargoes into the cytosol. These peptides are cyclized via side-chain alkylation, which makes them ideal for the creation of diverse mRNA or phage-displayed libraries with intrinsic cell permeability.
An integrated platform approach enables discovery of potent, selective and ligand-competitive cyclic peptides targeting the GIP receptor

Bhaskar Bhushan,Daniele Granata,Christian S. Kaas,Marina A. Kasimova,Qiansheng Ren,Christian N. Cramer,Mark D. White,Ann Maria K. Hansen,Christian Fledelius,Gaetano Invernizzi,Kristine Deibler,Oliver D. Coleman,Xin Zhao,Xinping Qu,Haimo Liu,Silvana S. Zurmühl,Janos T. Kodra,Akane Kawamura,Martin Münzel

DOI: https://doi.org/10.1039/d1sc06844j

IF: 8.4

2022-01-01

Chemical Science

Abstract:mRNA display generates vast datasets of protein binders. Bioinformatic clustering of the sequences combined with high throughput synthesis and analysis methods allow efficient prioritisation of hits for in vivo experiments.

chemistry, multidisciplinary
Design of Thioether Cyclic Peptide Scaffolds with Passive Permeability and Oral Exposure

Andrei A. Golosov,Alec N. Flyer,Jakal Amin,Charles Babu,Christian Gampe,Jingzhou Li,Eugene Liu,Katsumasa Nakajima,David Nettleton,Tajesh J. Patel,Patrick C. Reid,Lihua Yang,Lauren G. Monovich

DOI: https://doi.org/10.1021/acs.jmedchem.0c01505

IF: 8.039

2021-02-25

Journal of Medicinal Chemistry

Abstract:Advances in the design of permeable peptides and in the synthesis of large arrays of macrocyclic peptides with diverse amino acids have evolved on parallel but independent tracks. Less precedent combines their respective attributes, thereby limiting the potential to identify permeable peptide ligands for key targets. Herein, we present novel 6-, 7-, and 8-mer cyclic peptides (MW 774–1076 g·mol<sup>–1</sup>) with passive permeability and oral exposure that feature the amino acids and thioether ring-closing common to large array formats, including DNA- and RNA-templated synthesis. Each oral peptide herein, selected from virtual libraries of partially N-methylated peptides using <i>in silico</i> methods, reflects the subset consistent with low energy conformations, low desolvation penalties, and passive permeability. We envision that, by retaining the backbone N-methylation pattern and consequent bias toward permeability, one can generate large peptide arrays with sufficient side chain diversity to identify permeability-biased ligands to a variety of protein targets.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c01505?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01505</a>.Supplemental Table 1, Supplemental Figures S1–S4, and LCMS traces for compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01505/suppl_file/jm0c01505_si_001.pdf">PDF</a>)Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01505/suppl_file/jm0c01505_si_002.csv">CSV</a>)This article has not yet been cited by other publications.

chemistry, medicinal
Isothiocyanate Enabled Versatile Cyclizations of Phage Dis-played Peptides for the Discovery of Macrocyclic Binders

Xinxiang Lei,Liwen Bai,Ting Dan,Peng Cheng,Xiaoqin Yang,Hua Xiang,Rong Huang,Qi Wang,Kai Li,JinMing Gao

DOI: https://doi.org/10.26434/chemrxiv-2024-zh6t7

2024-10-16

Abstract:Cyclic peptides exhibit advantages in binding protein targets with high affinity and competency in inhibiting protein-protein interactions (PPIs). Cyclic peptide phage display with over a billion variants is an invaluable tool in drug discovery. However, achieving efficient peptide cyclization on phages remains a challenge due to the limited availability of reaction sites, which also restricts scaffold diversity. Here, we report an isothiocyanate-derived crosslinker featuring dual reactive groups: a bro-mide that covalently attaches to cysteine thiols, and a thiocyanogen that selectively forms a thiourea bridge with either the N-terminal amino group or ε-amines of lysine, depending on pH. This strategy enables pH-modulated cyclization, with head-to-side chain cyclization at pH 6.5 and side chain-to-side chain ligation at pH 9.5, simultaneously generating thiourea scaffolds. To demonstrate the versatility and biocompatibility of this approach, we constructed cyclic peptide libraries using both cy-clization methods and successfully selected binders for several targets, including Cyp D, TNF, MDM2, and Keap1, with disso-ciation constants (KD) ranging from micromolar to nanomolar. Given the broad pharmacological potential of the thiourea moiety, this phage display library opens new chemical space with high scaffold diversity and the integration of a proven pharmacophore for the development of cyclic peptide therapeutics.

Chemistry
CSM‐peptides: A computational approach to rapid identification of therapeutic peptides

Carlos H. M. Rodrigues,Anjali Garg,David Keizer,Douglas E. V. Pires,David B. Ascher

DOI: https://doi.org/10.1002/pro.4442

IF: 8

2022-09-30

Protein Science

Abstract:Peptides are attractive alternatives for the development of new therapeutic strategies due to their versatility and low complexity of synthesis. Increasing interest in these molecules has led to the creation of large collections of experimentally characterized therapeutic peptides, which greatly contributes to development of data‐driven computational approaches. Here we propose CSM‐peptides, a novel machine learning method for rapid identification of eight different types of therapeutic peptides: anti‐angiogenic, anti‐bacterial, anti‐cancer, anti‐inflammatory, anti‐viral, cell‐penetrating, quorum sensing, and surface binding. Our method has shown to outperform existing approaches, achieving an AUC of up to 0.92 on independent blind tests, and consistent performance on cross‐validation. We anticipate CSM‐peptides to be of great value in helping screening large libraries to identify novel peptides with therapeutic potential and have made it freely available as a user‐friendly web server and Application Programming Interface at https://biosig.lab.uq.edu.au/csm_peptides.

biochemistry & molecular biology
Development and Application of SPOSiPs: A Class of Diphosphine Ligands Based on SPOSiOL

Ze-Dong Li,Fei Ren,Yichen Wu,Jian-Jun Li,Junfei Luo,Peng Wang

DOI: https://doi.org/10.1021/acs.orglett.4c02784

IF: 5.2

2024-08-28

Organic Letters

Abstract:Here, we report the development and application of a novel class of spirosilacycle-based diphosphine ligands (SPOSiPs). This type of diphosphine ligand could be readily prepared in two steps with high efficiency starting from enantiopure spirobiphenoxasilin-diol (SPOSiOL). According to the structural analysis of SPOSiP and its PdCl(2) complex, SPOSiPs possess a flexible chiral pocket and feature a rigid configuration, a large dihedral angle, a long P-P distance, and a large P-M-P bite angle in...

chemistry, organic

SICLOPPS cyclic peptide libraries in drug discovery.

Next Generation SICLOPPS Screening for the Identification of Inhibitors of the HIF-1α/HIF-1β Protein-Protein Interaction

Methods for generating and screening libraries of genetically encoded cyclic peptides in drug discovery

A Tag‐Free Platform for Synthesis and Screening of Cyclic Peptide Libraries

Design of cyclic peptides as novel inhibitors of ICOS/ICOSL interaction

Imbuing peptide libraries with drug-likeness

Tetrazine cyclized peptides for one-bead-one-compound library: Synthesis and sequencing

A novel cyclic peptide library immobilized on gel‐type beads focusing on rapid construction and characterization for comprehensive drug discovery

Screening macrocyclic peptide libraries by yeast display allows control of selection process and affinity ranking

Large Libraries of Structurally Diverse Macrocycles Suitable for Membrane Permeation

Linearizable Macrocyclic Peptide Libraries for Affinity Selection-Mass Spectrometry

The coming of age of cyclic peptide drugs: an update on discovery technologies

CyclicPepedia: a knowledge base of natural and synthetic cyclic peptides

Selection of Nucleotide-Encoded Mass Libraries of Macrocyclic Peptides for Inaccessible Drug Targets

Cyclotides, a Novel Ultrastable Polypeptide Scaffold for Drug Discovery

Cyclic, Cell-Penetrating Peptides Tailor-Made for the Creation of Peptide Libraries with Intrinsic Cell Permeability

An integrated platform approach enables discovery of potent, selective and ligand-competitive cyclic peptides targeting the GIP receptor

Design of Thioether Cyclic Peptide Scaffolds with Passive Permeability and Oral Exposure

Isothiocyanate Enabled Versatile Cyclizations of Phage Dis-played Peptides for the Discovery of Macrocyclic Binders

CSM‐peptides: A computational approach to rapid identification of therapeutic peptides

Development and Application of SPOSiPs: A Class of Diphosphine Ligands Based on SPOSiOL